Business · Companies · 2 hrs ago
EEII and Haute Capital Partners agree to exclusive talks on combination
EEII and Haute Capital Partners have agreed to exclusive talks about a possible strategic combination.
EEII is an investment company listed on Switzerland’s SIX exchange, while HCP is listed on BX Swiss.
The proposed deal would transfer all or nearly all of HCP’s holdings to EEII in exchange for newly issued EEII shares.
The companies are also considering whether HCP would buy additional new EEII shares for cash.
HCP’s shareholders could receive the EEII shares that HCP gets, but this would require the necessary approvals.
The exclusive period runs until the end of 2026, during which the companies plan to assess the businesses, conduct legal and financial checks, and prepare transaction documents.
The deal still depends on final contracts, approvals and other conditions, so it is not yet certain to go ahead.
EEII and Haute Capital Partners (HCP) have signed an exclusivity agreement to pursue a strategic combination.
The agreement follows a joint statement of intent made at the end of October and runs until the end of 2026.
EEII plans to acquire all or nearly all of HCP’s investments in exchange for newly issued EEII shares.
The parties will work on valuations, legal and financial due diligence, and transaction documents during the exclusivity period.
Any deal depends on definitive agreements, approvals from the relevant bodies and other conditions.
- Who
- EEII and Haute Capital Partners (HCP).
- What
- They signed an exclusivity agreement to pursue a strategic combination.
- When
- The agreement was reported on November 10, 2026, and the exclusivity period runs until the end of 2026.
- Where
- EEII is listed on SIX Swiss Exchange; HCP is listed on BX Swiss. A transaction location is not stated.
- Why
- The companies are exploring a combination in which EEII would acquire all or nearly all of HCP’s investments.
This story does not have two clearly opposing sides.
EEII and HCP made a joint statement of intent about a strategic combination.
EEII and HCP signed an exclusivity agreement.
The exclusivity period is scheduled to continue.
- Exclusivity period
- Until the end of 2026
- Proposed acquisition
- All or nearly all of HCP’s investments
- Proposed consideration
- Newly issued EEII shares
- Additional option under review
- HCP cash subscription for new EEII shares
- EEII listing
- SIX Swiss Exchange
- HCP listing
- BX Swiss